Log In
Print this Print this

afacifenacin fumarate (NS-986, SMP-986)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionDual muscarinic receptor antagonist and sodium channel blocker
Molecular Target Muscarinic receptor ; Sodium channel
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
Partner Nippon Shinyaku Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today